No Data
Express News | Eli Lilly and Co reached a strategic partnership with Radionetics.
U.S. stocks fluctuate | Eli Lilly and Co. fell 3.58% at the beginning of trading as Biden urges lower pharmaceutical prices.
On July 2, Glonhui reported that Eli Lilly and Co. (LLY.US) fell 3.58% to $881.6 in early trading on US stocks. In the news, Biden and Sanders wrote in a column in Today's USA that novo-nordisk a/s and Eli Lilly and Co's pricing is incredibly high and called for the reduction of pharmaceutical prices.
Eli Lilly History: Beyond the Ticker
The Investment Guide for the 2024 USA Election is here! The best deployment time has come. Which US stocks are worth paying attention to?
Bank of America stated that the average monthly ROI of the S&P 500 index in the fourth year of a presidential cycle shows mediocre performance from January to May, a summer rebound from June to August, a fall before the election in September to October, and a post-election rebound in November and December.
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices
Eli Lilly (LLY.SW) and Novo Nordisk (NOVO-B.CO) were singled out by US President Joe Biden for "price gouging" and "corporate greed" for the prices of their diabetes and obesity drugs in the country.
Biden and Sanders jointly pressure to demand Novo Nordisk and Eli Lilly to lower the price of weight loss drugs.
① Biden pointed out that the prices of pharmaceutical products from Novo-Nordisk and Eli Lilly and Co are "unreasonably high" and far exceed those of other countries, which is unacceptable. ② If these pharmaceutical companies refuse to significantly reduce prescription drug prices in the United States and end their greedy behavior, we will do "everything we can to help them stop this behavior."